<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <script async src="https://www.googletagmanager.com/gtag/js?id=G-901N2Y3CDZ"></script>
  <script>
    window.dataLayer = window.dataLayer || [];
    function gtag(){dataLayer.push(arguments);}
    gtag('js', new Date());
    gtag('config', 'G-901N2Y3CDZ');
  </script>
  <title>Drug Formulations Clause | Biotech NDA Clauses | Terms.Law</title>
  <meta name="description" content="NDA clause protecting drug formulations, delivery mechanisms, and manufacturing processes. 3 versions: balanced, disclosing party favor, receiving party favor. Copy-paste ready for biotech and pharma agreements.">
  <link rel="preconnect" href="https://fonts.googleapis.com">
  <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700;800&display=swap" rel="stylesheet">
  <style>
    :root {
      --primary: #2563eb;
      --primary-dark: #1d4ed8;
      --accent: #8b5cf6;
      --success: #10b981;
      --warning: #f59e0b;
      --danger: #ef4444;
      --dark: #0f172a;
      --dark-lighter: #1e293b;
      --gray-50: #f8fafc;
      --gray-100: #f1f5f9;
      --gray-200: #e2e8f0;
      --gray-300: #cbd5e1;
      --gray-400: #94a3b8;
      --gray-600: #475569;
      --gray-700: #334155;
      --gray-800: #1e293b;
    }

    * { box-sizing: border-box; margin: 0; padding: 0; }
    html { scroll-behavior: smooth; }
    body {
      font-family: 'Inter', -apple-system, BlinkMacSystemFont, sans-serif;
      background: var(--gray-50);
      color: var(--gray-700);
      line-height: 1.6;
    }

    .site-header {
      background: linear-gradient(135deg, #0f172a 0%, #1e293b 100%);
      position: sticky;
      top: 0;
      z-index: 1000;
      box-shadow: 0 4px 20px rgba(0,0,0,0.3);
    }
    .header-content {
      max-width: 1400px;
      margin: 0 auto;
      display: flex;
      align-items: center;
      padding: 0 24px;
      height: 60px;
    }
    .site-logo {
      font-size: 1.15rem;
      font-weight: 800;
      text-decoration: none;
      background: linear-gradient(135deg, #60a5fa 0%, #a78bfa 100%);
      -webkit-background-clip: text;
      -webkit-text-fill-color: transparent;
      margin-right: 32px;
    }
    .site-nav {
      display: flex;
      align-items: center;
      gap: 0;
      flex: 1;
    }
    .nav-link {
      display: flex;
      align-items: center;
      gap: 6px;
      padding: 18px 16px;
      color: #94a3b8;
      text-decoration: none;
      font-size: 14px;
      font-weight: 500;
      transition: all 0.2s;
    }
    .nav-link:hover { color: #fff; }
    .nav-cta {
      margin-left: auto;
      background: linear-gradient(135deg, #2563eb 0%, #7c3aed 100%);
      color: #fff !important;
      padding: 10px 20px !important;
      border-radius: 8px;
      font-weight: 600 !important;
    }

    .hub-subnav {
      background: linear-gradient(135deg, #1e293b 0%, #334155 100%);
      border-bottom: 1px solid rgba(255,255,255,0.1);
    }
    .hub-subnav-content {
      max-width: 1400px;
      margin: 0 auto;
      padding: 0 24px;
      display: flex;
      align-items: center;
      justify-content: space-between;
      height: 48px;
    }
    .hub-subnav-title { color: #94a3b8; font-size: 0.9rem; font-weight: 600; }
    .hub-subnav-tabs { display: flex; gap: 8px; }
    .hub-tab {
      padding: 8px 16px;
      color: #94a3b8;
      text-decoration: none;
      font-size: 0.85rem;
      font-weight: 500;
      border-radius: 6px;
      transition: all 0.2s;
    }
    .hub-tab:hover { background: rgba(255,255,255,0.1); color: #fff; }
    .hub-tab.active { background: rgba(37, 99, 235, 0.3); color: #60a5fa; }

    .breadcrumb {
      max-width: 900px;
      margin: 0 auto;
      padding: 1.5rem 2rem 0;
      font-size: 0.9rem;
    }
    .breadcrumb a { color: var(--primary); text-decoration: none; }
    .breadcrumb a:hover { text-decoration: underline; }
    .breadcrumb span { color: var(--gray-400); margin: 0 8px; }

    .clause-header {
      max-width: 900px;
      margin: 0 auto;
      padding: 2rem;
    }
    .clause-category {
      display: inline-block;
      background: linear-gradient(135deg, #dcfce7, #bbf7d0);
      color: #166534;
      padding: 6px 14px;
      border-radius: 100px;
      font-size: 0.8rem;
      font-weight: 600;
      margin-bottom: 1rem;
    }
    .clause-title {
      font-size: 2.25rem;
      font-weight: 800;
      color: var(--dark);
      margin-bottom: 1rem;
      line-height: 1.2;
    }
    .clause-meta {
      display: flex;
      gap: 1rem;
      flex-wrap: wrap;
      align-items: center;
    }
    .risk-badge {
      padding: 6px 14px;
      border-radius: 100px;
      font-size: 0.8rem;
      font-weight: 700;
      text-transform: uppercase;
    }
    .risk-badge.high { background: #fee2e2; color: #dc2626; }
    .risk-badge.medium { background: #fef3c7; color: #d97706; }
    .risk-badge.low { background: #dcfce7; color: #16a34a; }
    .versions-count {
      color: var(--gray-600);
      font-size: 0.9rem;
    }
    .industry-badge {
      display: inline-block;
      background: linear-gradient(135deg, #ede9fe, #ddd6fe);
      color: #7c3aed;
      padding: 6px 14px;
      border-radius: 100px;
      font-size: 0.8rem;
      font-weight: 600;
    }

    .main-content {
      max-width: 900px;
      margin: 0 auto;
      padding: 0 2rem 4rem;
    }

    .content-section {
      background: white;
      border-radius: 16px;
      padding: 2rem;
      margin-bottom: 2rem;
      border: 1px solid var(--gray-200);
    }
    .section-title {
      font-size: 1.25rem;
      font-weight: 700;
      color: var(--dark);
      margin-bottom: 1rem;
      display: flex;
      align-items: center;
      gap: 10px;
    }
    .section-icon {
      width: 32px;
      height: 32px;
      border-radius: 8px;
      display: flex;
      align-items: center;
      justify-content: center;
      font-size: 1rem;
    }
    .section-icon.blue { background: #dbeafe; }
    .section-icon.yellow { background: #fef3c7; }
    .section-icon.red { background: #fee2e2; }
    .section-icon.green { background: #dcfce7; }
    .section-icon.purple { background: #ede9fe; }

    .explanation-text {
      font-size: 1rem;
      line-height: 1.7;
      color: var(--gray-700);
    }

    .key-points {
      list-style: none;
    }
    .key-point {
      display: flex;
      gap: 12px;
      padding: 12px 0;
      border-bottom: 1px solid var(--gray-100);
    }
    .key-point:last-child { border-bottom: none; }
    .point-icon {
      width: 24px;
      height: 24px;
      border-radius: 50%;
      display: flex;
      align-items: center;
      justify-content: center;
      font-size: 0.75rem;
      flex-shrink: 0;
      margin-top: 2px;
      background: #dbeafe;
      color: var(--primary);
    }

    .version-tabs {
      display: flex;
      gap: 8px;
      margin-bottom: 1.5rem;
      border-bottom: 2px solid var(--gray-200);
      padding-bottom: 0;
    }
    .version-tab {
      padding: 12px 20px;
      border: none;
      background: none;
      font-size: 0.95rem;
      font-weight: 600;
      color: var(--gray-500);
      cursor: pointer;
      border-bottom: 3px solid transparent;
      margin-bottom: -2px;
      transition: all 0.2s;
    }
    .version-tab:hover { color: var(--gray-700); }
    .version-tab.active {
      color: var(--primary);
      border-bottom-color: var(--primary);
    }
    .version-tab.balanced { }
    .version-tab.disclosing-favor.active { color: #16a34a; border-bottom-color: #16a34a; }
    .version-tab.receiving-favor.active { color: #dc2626; border-bottom-color: #dc2626; }

    .version-content { display: none; }
    .version-content.active { display: block; }

    .version-description {
      background: var(--gray-50);
      border-radius: 8px;
      padding: 1rem;
      margin-bottom: 1rem;
      font-size: 0.9rem;
      color: var(--gray-600);
    }
    .version-description.balanced { border-left: 4px solid var(--primary); }
    .version-description.disclosing-favor { border-left: 4px solid #16a34a; }
    .version-description.receiving-favor { border-left: 4px solid #dc2626; }

    .clause-text-container {
      position: relative;
      background: var(--gray-800);
      border-radius: 12px;
      overflow: hidden;
    }
    .clause-text {
      padding: 1.5rem;
      font-family: 'Georgia', serif;
      font-size: 0.95rem;
      line-height: 1.8;
      color: #e2e8f0;
      white-space: pre-wrap;
      overflow-x: auto;
    }
    .copy-button {
      position: absolute;
      top: 12px;
      right: 12px;
      background: var(--primary);
      color: white;
      border: none;
      padding: 8px 16px;
      border-radius: 6px;
      font-size: 0.85rem;
      font-weight: 600;
      cursor: pointer;
      display: flex;
      align-items: center;
      gap: 6px;
      transition: all 0.2s;
    }
    .copy-button:hover { background: var(--primary-dark); }
    .copy-button.copied { background: var(--success); }

    .nav-links {
      display: flex;
      justify-content: space-between;
      gap: 1rem;
      margin-top: 2rem;
      flex-wrap: wrap;
    }
    .nav-link-card {
      flex: 1;
      min-width: 200px;
      background: white;
      border: 2px solid var(--gray-200);
      border-radius: 12px;
      padding: 1.25rem;
      text-decoration: none;
      color: inherit;
      transition: all 0.2s;
    }
    .nav-link-card:hover {
      border-color: var(--primary);
      transform: translateY(-2px);
    }
    .nav-link-label {
      font-size: 0.8rem;
      color: var(--gray-500);
      margin-bottom: 4px;
    }
    .nav-link-title {
      font-weight: 600;
      color: var(--dark);
    }

    .footer {
      background: var(--dark);
      padding: 3rem 2rem;
      color: var(--gray-300);
    }
    .footer-inner {
      max-width: 1200px;
      margin: 0 auto;
      display: flex;
      justify-content: space-between;
      align-items: center;
      flex-wrap: wrap;
      gap: 1rem;
    }
    .footer-links { display: flex; gap: 2rem; }
    .footer-links a { color: var(--gray-300); text-decoration: none; font-size: 0.9rem; }
    .footer-links a:hover { color: white; }

    @media (max-width: 768px) {
      .clause-title { font-size: 1.75rem; }
      .version-tabs { overflow-x: auto; }
      .nav-links { flex-direction: column; }
    }
  </style>
</head>
<body>

<header class="site-header">
    <div class="header-content">
        <a href="/" class="site-logo">Terms.Law</a>
        <nav class="site-nav">
            <div class="nav-item">
                <a href="/Demand-Letters/" class="nav-link">Demands</a>
            </div>
            <div class="nav-item">
                <a href="/Templates/" class="nav-link">Contracts</a>
            </div>
            <div class="nav-item">
                <a href="/INC/" class="nav-link">Formation</a>
            </div>
            <div class="nav-item">
            </div>
            <div class="nav-item">
                <a href="/Blog/" class="nav-link">Read</a>
            </div>
            <a href="mailto:owner@terms.law" class="nav-link nav-cta">Contact</a>
        </nav>
    </div>
</header>

<nav class="hub-subnav">
  <div class="hub-subnav-content">
    <a href="/NDA/" class="hub-subnav-title">NDA Studio</a>
    <div class="hub-subnav-tabs">
      <a href="/NDA/" class="hub-tab">Generator</a>
      <a href="/NDA/clause-library/" class="hub-tab active">Clause Library</a>
      <a href="/NDA/scenarios/" class="hub-tab">Scenarios</a>
    </div>
  </div>
</nav>

<div class="breadcrumb">
  <a href="/">Terms.Law</a>
  <span>&#8250;</span>
  <a href="/NDA/">NDA Studio</a>
  <span>&#8250;</span>
  <a href="/NDA/clause-library/">Clause Library</a>
  <span>&#8250;</span>
  <a href="/NDA/clause-library/industries/biotech/">Biotech/Pharma</a>
  <span>&#8250;</span>
  Drug Formulations
</div>

<header class="clause-header">
  <div class="clause-category">Biotech/Pharma Industry</div>
  <h1 class="clause-title">Drug Formulations Protection</h1>
  <div class="clause-meta">
    <span class="risk-badge high">High Risk</span>
    <span class="versions-count">3 versions available</span>
    <span class="industry-badge">Industry-Specific</span>
  </div>
</header>

<main class="main-content">

  <section class="content-section">
    <h2 class="section-title">
      <span class="section-icon blue">&#128161;</span>
      Plain English Explanation
    </h2>
    <p class="explanation-text">
      This clause protects drug formulation information, including dosage forms, delivery mechanisms, excipient compositions, and manufacturing processes. Formulation know-how often represents the difference between a successful commercial product and a failed development program.
      <br><br>
      Drug formulations encompass the science of turning an active pharmaceutical ingredient (API) into a usable medicine. This includes tablets, capsules, injectables, patches, and advanced delivery systems like nanoparticles or liposomes. The formulation determines bioavailability, stability, patient compliance, and manufacturing feasibility.
      <br><br>
      <strong>This clause addresses critical formulation concerns:</strong>
    </p>
    <ul class="key-points" style="margin-top: 1rem;">
      <li class="key-point">
        <span class="point-icon">1</span>
        <div><strong>Formulation compositions.</strong> Exact quantities and ratios of APIs, excipients, preservatives, and functional ingredients that define a drug product.</div>
      </li>
      <li class="key-point">
        <span class="point-icon">2</span>
        <div><strong>Drug delivery technologies.</strong> Proprietary delivery mechanisms, controlled release systems, and targeting strategies that enable therapeutic efficacy.</div>
      </li>
      <li class="key-point">
        <span class="point-icon">3</span>
        <div><strong>Manufacturing processes.</strong> Scale-up procedures, equipment specifications, process parameters, and quality control methods essential for commercial production.</div>
      </li>
    </ul>
  </section>

  <section class="content-section">
    <h2 class="section-title">
      <span class="section-icon yellow">&#9888;</span>
      Why This Clause Matters
    </h2>
    <p class="explanation-text">
      <strong>For the Disclosing Party (Formulation Developer):</strong> Formulation know-how is often your primary competitive advantage. Generic companies and competitors can potentially replicate a formulation if they understand your composition and process. This clause ensures that formulation details shared during licensing discussions, CMO evaluations, or partnership negotiations remain protected.
      <br><br>
      <strong>For the Receiving Party (Potential Partner/CMO):</strong> You need formulation details to evaluate manufacturing feasibility, estimate costs, and assess technical fit. However, you may work with competing products and need clarity on information segregation requirements.
      <br><br>
      <strong>Trade Secret Considerations:</strong> Unlike patents, formulation trade secrets can provide indefinite protection if properly maintained. The clause must support trade secret status by documenting confidential treatment and limiting disclosure to those with a need to know.
    </p>
  </section>

  <section class="content-section">
    <h2 class="section-title">
      <span class="section-icon purple">&#128196;</span>
      Clause Versions
    </h2>

    <div class="version-tabs">
      <button class="version-tab balanced active" data-version="balanced">Balanced</button>
      <button class="version-tab disclosing-favor" data-version="disclosing-favor">Disclosing Party Favor</button>
      <button class="version-tab receiving-favor" data-version="receiving-favor">Receiving Party Favor</button>
    </div>

    <div class="version-content balanced active" id="version-balanced">
      <div class="version-description balanced">
        <strong>Balanced Version:</strong> Comprehensive protection for formulation information with practical carve-outs for publicly disclosed compositions and standard manufacturing practices. Suitable for CMO evaluations, partnership discussions, and licensing negotiations.
      </div>
      <div class="clause-text-container">
        <button class="copy-button" onclick="copyClause(this)">
          <span>&#128203;</span> Copy
        </button>
        <pre class="clause-text">"Formulation Information" means Confidential Information relating to drug formulations, dosage forms, drug delivery systems, and pharmaceutical manufacturing, including without limitation:

(a) formulation compositions, including quantitative and qualitative descriptions of active pharmaceutical ingredients, excipients, carriers, solvents, preservatives, and other ingredients;

(b) drug delivery technologies, including controlled release systems, targeted delivery mechanisms, nanoparticle formulations, liposomal formulations, and transdermal delivery systems;

(c) dosage form specifications, including tablets, capsules, injectables, patches, gels, creams, and other pharmaceutical presentations;

(d) manufacturing processes, including batch formulas, unit operations, equipment specifications, process parameters, and in-process controls;

(e) stability data, including accelerated and long-term stability studies, degradation pathways, and shelf-life determinations;

(f) analytical methods, including assays, dissolution testing, impurity profiling, and release specifications; and

(g) scale-up and technology transfer documentation, including pilot batch records, process validation protocols, and commercial manufacturing procedures.

The Receiving Party agrees that Formulation Information shall be used solely for evaluating a potential business relationship and shall not be used to:
(i) develop competing formulations for the same active pharmaceutical ingredient;
(ii) manufacture any product using disclosed formulation or process information without written authorization; or
(iii) file any regulatory submission incorporating Formulation Information without prior consent.

Formulation Information does not include:
(i) information disclosed in approved product labels, package inserts, or publicly available regulatory documents;
(ii) standard pharmaceutical manufacturing practices widely known in the industry; or
(iii) information disclosed in issued patents or published patent applications.</pre>
      </div>
    </div>

    <div class="version-content disclosing-favor" id="version-disclosing-favor">
      <div class="version-description disclosing-favor">
        <strong>Disclosing Party Favor:</strong> Maximum protection for formulation trade secrets, including restrictions on reverse engineering and competitive development. Extended confidentiality periods and strong personnel segregation requirements. Ideal for sharing proprietary delivery technology platforms.
      </div>
      <div class="clause-text-container">
        <button class="copy-button" onclick="copyClause(this)">
          <span>&#128203;</span> Copy
        </button>
        <pre class="clause-text">"Formulation Information" means all information of any kind relating to drug formulations, pharmaceutical compositions, drug delivery systems, and manufacturing processes, including without limitation:

(a) all formulation compositions, including complete quantitative formulas, ingredient specifications, grade requirements, supplier information, and all ratios and proportions of active and inactive ingredients;

(b) all drug delivery technologies and platforms, including controlled release mechanisms, modified release systems, extended release technologies, targeted delivery systems, nanoparticle and liposomal formulations, polymer matrices, and any proprietary delivery technology;

(c) all dosage form information, including tablet designs, capsule specifications, injectable presentations, implant configurations, transdermal systems, and any specialized pharmaceutical forms;

(d) all manufacturing process information, including batch formulas, unit operations sequences, equipment types and settings, process parameters, temperature profiles, mixing speeds, compression forces, coating conditions, and all critical process parameters;

(e) all process development information, including design of experiments data, process optimization studies, design space definitions, and scale-up methodologies;

(f) all stability information, including stability protocols, stability data (accelerated, intermediate, and long-term), photostability data, stress testing results, degradation products, and stability-indicating methods;

(g) all analytical information, including method development, validation data, specifications, acceptance criteria, and reference standard information;

(h) all quality information, including quality attributes, critical quality attributes, control strategies, and specification justifications;

(i) all manufacturing site information, including facility layouts, equipment trains, environmental controls, and cleaning procedures; and

(j) all know-how, techniques, and expertise developed in connection with formulation development and manufacturing.

The Receiving Party shall:
(i) not reverse engineer, analyze, or characterize any samples provided in connection with this Agreement;
(ii) not develop any formulation for the same or similar active pharmaceutical ingredient;
(iii) not share Formulation Information with manufacturing personnel working on competing products;
(iv) implement information barriers to prevent Formulation Information from being accessible to personnel working on competitive products;
(v) not use Formulation Information to evaluate, develop, or manufacture any product for third parties; and
(vi) maintain Formulation Information as a trade secret for a period of fifteen (15) years following disclosure or for so long as the information remains a trade secret, whichever is longer.

For any physical samples provided, the Receiving Party shall:
(i) use samples solely for purposes expressly authorized in writing;
(ii) not conduct any analytical testing, dissolution studies, or reverse engineering without prior written consent;
(iii) return or destroy all samples upon request or termination of discussions; and
(iv) not retain any portion of samples for reference or archive purposes.</pre>
      </div>
    </div>

    <div class="version-content receiving-favor" id="version-receiving-favor">
      <div class="version-description receiving-favor">
        <strong>Receiving Party Favor:</strong> Narrower definition focused on specific proprietary formulations with carve-outs for standard industry practices and published information. Preserves right to work on similar products and conduct necessary analytical testing. Suitable for CMOs with diverse client bases.
      </div>
      <div class="clause-text-container">
        <button class="copy-button" onclick="copyClause(this)">
          <span>&#128203;</span> Copy
        </button>
        <pre class="clause-text">"Formulation Information" means only that information which:

(a) relates specifically to the drug formulation(s) identified in Exhibit A (the "Designated Formulations"); and

(b) is disclosed in writing and clearly marked as "Confidential Formulation Information."

Formulation Information includes only:
(i) the specific quantitative formula for Designated Formulations as provided in writing;
(ii) manufacturing process parameters specific to Designated Formulations;
(iii) stability data specific to Designated Formulations; and
(iv) analytical methods developed specifically for Designated Formulations.

Formulation Information expressly does not include:
(i) standard pharmaceutical excipients, carriers, or inactive ingredients commonly used in the industry;
(ii) general formulation principles, techniques, or methodologies applicable to pharmaceutical development;
(iii) standard manufacturing processes, unit operations, or equipment settings commonly used for similar dosage forms;
(iv) information disclosed in drug product labels, package inserts, or publicly available regulatory documents;
(v) information disclosed in patents or published patent applications;
(vi) information that the Receiving Party can demonstrate was in its possession prior to disclosure;
(vii) information independently developed by the Receiving Party without use of Formulation Information; or
(viii) standard analytical methods described in pharmacopoeias or industry guidance.

The Receiving Party may:
(i) conduct analytical testing reasonably necessary to evaluate the Designated Formulations for the proposed business purpose;
(ii) work on formulations for other clients, including formulations for similar therapeutic categories;
(iii) use general knowledge, skills, and experience gained during the evaluation, provided such use does not involve disclosure of specific Formulation Information;
(iv) retain one archival copy of Formulation Information for legal compliance purposes; and
(v) share Formulation Information with subcontractors and consultants under appropriate confidentiality obligations.

Confidentiality obligations with respect to Formulation Information shall terminate upon the earlier of:
(i) five (5) years from disclosure;
(ii) public disclosure of such information through regulatory approval or patent publication; or
(iii) written confirmation from the Disclosing Party that the information is no longer confidential.</pre>
      </div>
    </div>
  </section>

  <section class="content-section">
    <h2 class="section-title">
      <span class="section-icon green">&#128172;</span>
      Key Considerations
    </h2>
    <ul class="key-points">
      <li class="key-point">
        <span class="point-icon">&#10003;</span>
        <div>
          <strong>Address sample handling explicitly.</strong> If physical samples will be shared, specify permitted testing, storage requirements, and return/destruction obligations.
        </div>
      </li>
      <li class="key-point">
        <span class="point-icon">&#10003;</span>
        <div>
          <strong>Consider CMO-specific concerns.</strong> Contract manufacturing organizations work with many clients. Address information barriers and personnel segregation requirements.
        </div>
      </li>
      <li class="key-point">
        <span class="point-icon">&#10003;</span>
        <div>
          <strong>Protect manufacturing know-how separately.</strong> Tacit knowledge and process expertise may be more valuable than documented formulations. Consider how to address implicit knowledge transfer.
        </div>
      </li>
      <li class="key-point">
        <span class="point-icon">&#10003;</span>
        <div>
          <strong>Plan for regulatory disclosure.</strong> CMC sections of regulatory filings disclose formulation details. Structure confidentiality obligations to survive regulatory disclosure where appropriate.
        </div>
      </li>
      <li class="key-point">
        <span class="point-icon">&#10003;</span>
        <div>
          <strong>Address delivery technology platforms.</strong> If the formulation involves proprietary delivery technology, consider whether platform-level protection is needed beyond product-specific information.
        </div>
      </li>
    </ul>
  </section>

  <nav class="nav-links">
    <a href="/NDA/clause-library/industries/biotech/patents.html" class="nav-link-card">
      <div class="nav-link-label">&#8592; Previous</div>
      <div class="nav-link-title">Patent Information</div>
    </a>
    <a href="/NDA/clause-library/" class="nav-link-card">
      <div class="nav-link-label">Back to &#8594;</div>
      <div class="nav-link-title">Clause Library</div>
    </a>
  </nav>

</main>

<footer class="footer">
  <div class="footer-inner">
    <div>&copy; 2025 Terms.Law &mdash; Sergei Tokmakov, Esq. &bull; CA Bar #279869</div>
    <div class="footer-links">
      <a href="#">Privacy Policy</a>
      <a href="#">Terms of Service</a>
      <a href="#">Contact</a>
    </div>
  </div>
</footer>

<script>
  // Tab switching
  document.querySelectorAll('.version-tab').forEach(tab => {
    tab.addEventListener('click', () => {
      document.querySelectorAll('.version-tab').forEach(t => t.classList.remove('active'));
      document.querySelectorAll('.version-content').forEach(c => c.classList.remove('active'));

      tab.classList.add('active');
      document.getElementById('version-' + tab.dataset.version).classList.add('active');
    });
  });

  // Copy functionality
  function copyClause(button) {
    const clauseText = button.parentElement.querySelector('.clause-text').textContent;
    navigator.clipboard.writeText(clauseText).then(() => {
      button.innerHTML = '<span>&#10003;</span> Copied!';
      button.classList.add('copied');
      setTimeout(() => {
        button.innerHTML = '<span>&#128203;</span> Copy';
        button.classList.remove('copied');
      }, 2000);
    });
  }
</script>

</body>
</html>
